Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis

Several new drugs are progressively improving the life span of patients with B-cell chronic lymphocytic leukemia (CLL). However, the rapidly evolving standard of care precludes robust assessments of the incremental clinical value of further innovative drugs. Therefore, we systematically reviewed com...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Monia, Rivela, Paolo, Bertassello, Claudia, Canicattì, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999707/
https://www.ncbi.nlm.nih.gov/pubmed/35407474
http://dx.doi.org/10.3390/jcm11071868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999707/
https://www.ncbi.nlm.nih.gov/pubmed/35407474
http://dx.doi.org/10.3390/jcm11071868

Ejemplares similares